Skip to content
CONMED logo

CONMED

CNMD

CONMED Corporation is a medical technology company that specializes in the development and manufacture of surgical devices and equipment.

Market cap
$1.33B-14.1%
Revenue$1.4B+3.4%
Net income$56.5M-48.7%
Free cash flow$134.5M-9.3%
EPS (diluted)$1.85-47.6%
Trailing twelve months · change vs. prior year

Earnings

Next report

Oct 28, 2026 (in 3 months)
Revenue estimate$334.9M
EPS estimate$1.03

Financials

Q2 2026

Income statement

See full
Revenue$343.5M+0.3%
Gross profit$197.5M+4.9%
Operating income$36.4M-4.6%
Net income$23.1M+7.7%
EPS (diluted)$0.77+11.6%

Balance sheet

See full
Cash & equivalents$37.3M+10.0%
Total debt$1.0B+14.5%
Total equity$1.0B+3.8%
Total assets$2.3B-1.2%

Cash flow

See full
Operating cash flow$37.1M+27.3%
CapEx$2.9M-48.8%
Free cash flow$34.2M+46.0%

Valuation & ratios

Valuation

See full
Market cap$1.33B-14.1%
Enterprise value$2.31B-4.1%
P/E23.6×+9.5×
P/S-0.2×

Profitability

See full
Gross margin55.8%-0.3pp
Operating margin8%-5.0pp
Net margin4.1%-4.2pp
FCF margin9.8%-1.4pp

Returns & leverage

See full
Return on equity5.5%-6.2pp
Debt / equity+0.1×
Current ratio1.5×-0.7×

Segments

By geography

See full
Europe, Middle East & Africa$76.1M+12.3%
Asia Pacific$57.2M+9.7%
Americas (excluding the United States)$34.8M+9.2%

By product

See full
General Surgery$191.2M-5.2%
Orthopedic Surgery$152.3M+8.2%

Competitors

Profile

CONMED Corporation is a medical technology company that specializes in the development and manufacture of surgical devices and equipment. The company provides innovative solutions for minimally invasive procedures across specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its core value proposition centers on improving patient outcomes through high-quality surgical tools, visualization systems, and tissue repair technologies distributed globally.

Competitive position

CONMED is a leading provider of specialized surgical equipment, particularly in the niche markets of insufflation and smoke evacuation, while maintaining a strong recurring revenue base through single-use disposables.

GeographiesUnited States, Europe, Latin America, Canada, Asia/Pacific Rim
Customer segmentsHospitals, Surgery Centers, Group Purchasing Organizations (GPOs), Integrated Delivery Networks (IDNs)
Business modelManufacturing, Direct Sales, Recurring Revenue (Single-use disposables)
SuppliersRaw material suppliers, Electronic component manufacturers, Ethylene Oxide (EtO) sterilization service providers, Allograft tissue donors
CustomersHospitals, Outpatient surgery centers, Veterans Administration, Medical specialty distributors
Listed1987
Employees4.0K
CEOPatrick J. Beyer
Websiteconmed.com
FilingsSEC EDGAR

Questions, answered.

What is CONMED's market cap?
CONMED (CNMD) has a market capitalization of $1.3B and trades on NYSE.
What is CONMED's revenue and profitability?
CONMED generated $1.4B in trailing twelve-month revenue with net income of $56.5M, representing a net margin of 4.1%. Gross margin stands at 55.8%, with free cash flow of $134.5M. These figures are based on the Q2 2026 filing.
Who are CONMED's competitors?
CONMED's key competitors include Stryker Corporation, Medtronic plc, Boston Scientific Corporation, and others. These companies compete in similar markets and product categories.
Who does CONMED partner with?
CONMED's notable partners include W. L. Gore & Associates, Inc., Gallup.
What subsidiaries does CONMED have?
CONMED's subsidiaries include Buffalo Filter, LLC, Linvatec Corporation.
Where is CONMED headquartered?
CONMED is headquartered in United States of America and employs approximately 4,000 people. It has been publicly traded since 1987.